Article Details
Retrieved on: 2024-07-27 06:08:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca CEO Pascal Soriot urges the UK government to reassess drug funding after NICE deems Enhertu too costly, highlighting concerns over new ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here